Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo

Life Sciences

Volumn 80, Issue 23, 2007, Pages 2154-2160

  Fang, Lu ^a,b   Moore, Xiao Lei ^a   Gao, Xiao Ming ^a   Dart, Anthony M ^a   Lim, Yean Leng ^b   Du, Xiao Jun ^a  

^a ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cardiac hypertrophy; Gene expression; Mitofusin 2

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA 2 ADRENERGIC RECEPTOR; MEMBRANE PROTEIN; MITOFUSIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; WESTERN BLOTTING;

ANIMALS; CARDIOMEGALY; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GTP PHOSPHOHYDROLASES; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY;

MUS; RATTUS;

EID: 34248572358     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.04.003     Document Type: Article

References (32)

1. Autelitano D.J., and Woodcock E.A. Selective activation of α1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of α1-adrenergic receptor subtype mRNAs. Journal of Molecular and Cellular Cardiology 30 (1998) 1515-1523
2. Bach D., Naon D., Pich S., Soriano F.X., Vega N., Rieusset J., Laville M., Guillet C., Boirie Y., Wallberg-Henriksson H., Manco M., Calvani M., Castagneto M., Palacin M., Mingrone G., Zierath J.R., Vidal H., and Zorzano A. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor α and interleukin-6. Diabetes 54 (2005) 2685-2693
3. Bach D., Pich S., Soriano F.X., Vega N., Baumgartner B., Oriola J., Daugaard J.R., Lloberas J., Camps M., Zierath J.R., Rabasa-Lhoret R., Wallberg-Henriksson H., Laville M., Palacin M., Vidal H., Rivera F., Brand M., and Zorzano A. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism A novel regulatory mechanism altered in obesity. Journal of Biological Chemistry 278 (2003) 17190-17197
4. Bogoyevitch M.A., Gillespie-Brown J., Ketterman A.J., Fuller S.J., Ben-Levy R., Ashworth A., Marshall C.J., and Sugden P.H. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circulation Research 79 (1996) 162-173
5. Bueno O.F., De Windt L.J., Tymitz K.M., Witt S.A., Kimball T.R., Klevitsky R., Hewett T.E., Jones S.P., Lefer D.J., Peng C.F., Kitsis R.N., and Molkentin J.D. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. Embo Journal 19 (2000) 6341-6350
6. Chen H., and Chan D.C. Critical dependence of neurons on mitochondrial dynamics. Current Opinion in Cell Biology 18 (2006) 453-459
7. Chen H., Detmer S.A., Ewald A.J., Griffin E.E., Fraser S.E., and Chan D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. Journal of Cell Biology 160 (2003) 189-200
8. Chen K.H., Guo X., Ma D., Guo Y., Li Q., Yang D., Li P., Qiu X., Wen S., Xiao R.P., and Tang J. Dysregulation of HSG triggers vascular proliferative disorders. Nature Cell Biology 6 (2004) 872-883
9. Douglas P.S., Katz S.E., Weinberg E.O., Chen M.H., Bishop S.P., and Lorell B.H. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. Journal of the American College of Cardiology 32 (1998) 1118-1125
10. 2-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. Circulation 101 (2000) 71-77
11. 2-adrenergic receptors. American Journal of Physiology Heart and Circulatory Physiology 279 (2000) H2456-H2463
12. 2-adrenergic receptors in the heart. Cardiovascular Research 48 (2000) 448-454
13. Esposito G., Prasad S.V., Rapacciuolo A., Mao L., Koch W.J., and Rockman H.A. Cardiac overexpression of a Gq inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation 103 (2001) 1453-1458
14. 2-adrenergic receptor overexpression. Endocrinology 144 (2003) 4097-4105
15. Gao X.M., Wong G., Wang B., Kiriazis H., Moore X.L., Su Y.D., Dart A., and Du X.J. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. Journal of Hypertension 24 (2006) 1663-1670
16. Glennon P.E., Kaddoura S., Sale E.M., Sale G.J., Fuller S.J., and Sugden P.H. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circulation Research 78 (1996) 954-961
17. Gosselin H., Beliveau L., Burelle Y., Clement R., Lajoie C., El-Helou V., and Calderone A. Disparate regulation of signaling proteins after exercise and myocardial infarction. Medicine and Science in Sports and Exercise 38 (2006) 455-462
18. Kacimi R., and Gerdes A.M. Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension 41 (2003) 968-977
19. Knowles J.W., Esposito G., Mao L., Hagaman J.R., Fox J.E., Smithies O., Rockman H.A., and Maeda N. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. Journal of Clinical Investigation 107 (2001) 975-984
20. Levy D., Garrison R.J., Savage D.D., Kannel W.B., and Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New England Journal of Medicine 322 (1990) 1561-1566
21. 2-adrenergic receptor mediates extracellular signal regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. Journal of Biological Chemistry 275 (2000) 9572-9580
22. Melchert R.B., Liu H., Granberry M.C., and Kennedy R.H. Lovastatin inhibits phenylephrine-induced ERK activation and growth of cardiac. Cardiovascular Toxicology 1 (2001) 237-252
23. 2-adrenergic receptor. Science 264 (1994) 582-586
24. Qin F., Liang M.C., and Liang C.S. Progressive left ventricular remodeling, myocyte apoptosis, and protein signaling cascades after myocardial infarction in rabbits. Biochimica et Biophysica Acta 1740 (2005) 499-513
25. Pawlikowska P., Gajkowska B., and Orzechowski A. Mitofusin 2 (Mfn2): a key player in insulin-dependent myogenesis in vitro. Cell and Tissue Research 327 (2007) 571-581
26. Schmieder R.E., Martus P., and Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension A meta-analysis of randomized double-blind studies. The Journal of American Medical Association 275 (1996) 1507-1513
27. Shimizu N., Yoshiyama M., Omura T., Hanatani A., Kim S., Takeuchi K., Iwao H., and Yoshikawa J. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovascular Research 38 (1998) 116-124
28. Skavdahl M., Steenbergen C., Clark J., Myers P., Demianenko T., Mao L., Rockman H.A., Korach K.S., and Murphy E. Estrogen receptor-β mediates male-female differences in the development of pressure overload hypertrophy. American Journal of Physiology. Heart and Circulatory Physiology 288 (2005) H469-H476
29. Soriano F.X., Liesa M., Bach D., Chan D.C., Palacin M., and Zorzano A. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-{gamma} coactivator-1{alpha}, estrogen-related receptor-{alpha}, and mitofusin 2. Diabetes 55 (2006) 1783-1791
30. van Eickels M., Grohe C., Cleutjens J.P., Janssen B.J., Wellens H.J., and Doevendans P.A. 17β-estradiol attenuates the development of pressure-overload hypertrophy. Circulation 104 (2001) 1419-1423
31. Verdecchia P., Angeli F., Borgioni C., Gattobigio R., de Simone G., Devereux R.B., and Porcellati C. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. American Journal of Hypertension 16 (2003) 895-899
32. Verdecchia P., Carini G., Circo A., Dovellini E., Giovannini E., Lombardo M., Solinas P., Gorini M., and Maggioni A.P. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. Journal of the American College Cardiology 38 (2001) 1829-1835